RENEE RUBINSTEIN: Open Payments
NPI 1619102233 · CORAOPOLIS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$664 in 36 payments from 14 companies in 2025. Trend: 2023 $772 · 2024 $581 · 2025 $664
Food & beverage: $664
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $103 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $93 |
| GlaxoSmithKline, LLC. | 5 | $87 |
| PFIZER INC. | 4 | $81 |
| Collegium Pharmaceutical, Inc. | 3 | $61 |
| Lilly USA, LLC | 2 | $38 |
| Kowa Pharmaceuticals America, Inc. | 2 | $35 |
| Teva Pharmaceuticals USA, Inc. | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Daiichi Sankyo Inc. | 1 | $25 |
Products named: CAPLYTA, TRELEGY ELLIPTA, NURTEC ODT, Belbuca, VRAYLAR, MOUNJARO, ZORYVE, UBRELVY.
Industry payments across PA — which companies pay providers there.
